Clinical Trial Update: Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing telpegfilgrastim with filgrastim for secondary prevention of chemotherapy-induced neutropenia in pediatric solid tumors;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Solid Tumors

Drugs mentioned

• Filgrastim (filgrastim)
• Telpegfilgrastim (telpegfilgrastim)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Solid Tumors, Children | Phase 2 | Status: NOT_YET_RECRUITING